Chronic myeloid leukemia, BCR/ABL-positive, in remission

This code signifies a diagnosis of chronic myeloid leukemia (CML) that is characterized by the presence of the BCR/ABL fusion gene, indicating a specific genetic abnormality. The "in remission" status denotes that the disease is currently controlled, with no active signs or symptoms of leukemia. This typically means the patient has achieved a complete molecular or cytogenetic response to treatment.

Apply this code when documentation confirms a patient has BCR/ABL-positive CML and is currently in a state of remission following treatment. This is appropriate for ongoing management and surveillance of patients who have responded well to therapy, such as tyrosine kinase inhibitors. Supporting documentation should explicitly state "in remission" or provide evidence of molecular or cytogenetic remission.

• Ensure documentation clearly specifies "BCR/ABL-positive" as CML can be BCR/ABL-negative, which codes differently.
• Distinguish from C92.10 (not having achieved remission) and C92.12 (in relapse), as the remission status is crucial for accurate coding.
• Always sequence this code as a primary diagnosis when the patient is being seen for ongoing management of their CML in remission.